| Q1 | Q2 | Q3 | Q4 | P trendb | |||
---|---|---|---|---|---|---|---|---|
Men | ||||||||
Cases/controls (n) | 210/1056 | 261/1058 | 242/1057 | 344/1056 | Â | |||
Range DII score | –4.16 – -0.25 | –0.25 – 1.05 | 1.05 – 2.16 | 2.16 – 4.72 |  | |||
 | OR | OR | 95% CI | OR | 95% CI | OR | 95% CI |  |
Energy-adjustedc | ref | 1.22 | 0.98–1.51 | 1.12 | 0.88–1.42 | 1.57 | 1.21–2.02 | 0.018 |
Multivariabled | ref | 1.20 | 0.95–1.53 | 1.13 | 0.87–1.45 | 1.50 | 1.14–1.99 | 0.097 |
Women | ||||||||
Cases/controls (n) | 75/332 | 90/332 | 72/332 | 95/332 | Â | |||
Range DII score | –3.86 – 0.00 | 0.00 – 1.29 | 1.29 – 2.31 | 2.31 – 4.31 |  | |||
 | OR | OR | 95% CI | OR | 95% CI | OR | 95% CI |  |
Energy-adjustedc | ref | 1.09 | 0.75–1.58 | 0.82 | 0.54–1.23 | 1.01 | 0.65–1.56 | 0.423 |
Multivariabled | ref | 1.05 | 0.69–1.59 | 0.82 | 0.51–1.30 | 0.83 | 0.50–1.36 | 0.088 |